Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634569 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects
A Phase 4 study, sponsored by Instituto Grifols, S.A..
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00634569 is a Phase 4 study that has completed, run by Instituto Grifols, S.A.. The registered enrollment target is 24 participants.
The verdict
NCT00634569, a Phase 4 study, has completed, sponsored by Instituto Grifols, S.A..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a multi-center, open-label study to assess the efficacy and safety of Flebogamma 5% DIF in the pediatric population.
Interventions
- BIOLOGICAL Flebogamma 5% DIF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00634569
The ClinicalTrials.gov registry entry for NCT00634569 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Instituto Grifols, S.A., which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flebogamma 5% DIF is the first listed.
NCT00634569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00634569 about?
NCT00634569 is a clinical study titled "Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects". This is a multi-center, open-label study to assess the efficacy and safety of Flebogamma 5% DIF in the pediatric population.
What is the current status of trial NCT00634569?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2008-05. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00634569?
The interventions under investigation include: Flebogamma 5% DIF (BIOLOGICAL).
Who is sponsoring clinical trial NCT00634569?
This trial is sponsored by Instituto Grifols, S.A., which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.